Sharda Cropchem (SHARDACROP) Q4 24/25 earnings summary

Executive summary

• FY25 revenue grew 37% year-over-year to Rs. 4,320 crores, with Q4 FY25 revenue up 39% to Rs. 1,829 crores, driven by strong volume increases across all major regions and segments.

• Agrochemical segment contributed 87% of total revenues, with significant growth in herbicides, insecticides, and fungicides.

• Gross margin improved by 400 bps to 29.9% in FY25, with EBITDA more than doubling to Rs. 682 crores and PAT surging to Rs. 304 crores.

• Board approved audited consolidated and standalone financial results for FY25, with no audit qualifications from statutory auditors.

• Final dividend of Rs. 6 per equity share recommended for FY25, subject to shareholder approval.

Financial highlights

• FY25 revenue: Rs. 4,320 crores (+37% YoY); Q4 FY25 revenue: Rs. 1,829 crores (+39% YoY).

• FY25 EBITDA: Rs. 682 crores (+114% YoY); Q4 FY25 EBITDA: Rs. 352 crores (+16% YoY).

• FY25 PAT: Rs. 304 crores (+854% YoY); Q4 FY25 PAT: Rs. 204 crores (+42% YoY).

• Earnings per share for FY25: Rs. 33.74 (up from Rs. 3.53 in FY24).

• Cash and cash equivalents increased to Rs. 12,721.29 lakhs as of March 31, 2025.

Outlook and guidance

• Targeting over 15% top-line growth in FY26, with gross margins expected to improve as prices recover.

• EBITDA margin guidance maintained at 15%-18% for FY26.

• Board notes the seasonal nature of the agrochemicals segment, with performance impacted by cropping patterns and weather globally.